Amgen Inc. - Company & Market Research Reports

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Remicade (Infliximab) Biosimilar Clinical Trial Insight - Product Thumbnail Image

Remicade (Infliximab) Biosimilar Clinical Trial Insight

  • Clinical Trials
  • 50 Pages
From
Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors - Product Thumbnail Image

Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors

  • Report
  • 70 Pages
From
Humira Biosimilars Clinical Trial Insight - Product Thumbnail Image

Humira Biosimilars Clinical Trial Insight

  • Clinical Trials
  • 80 Pages
From
Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight - Product Thumbnail Image

Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight

  • Clinical Trials
  • 85 Pages
From
Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4)], By Application (Lung, Melanoma, Leukemia, Lymphoma) - Global Forecast to 2022 - Product Thumbnail Image

Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4)], By Application (Lung, Melanoma, Leukemia, Lymphoma) - Global Forecast to 2022

  • Report
  • 230 Pages
From
The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis - Product Thumbnail Image

The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis

  • Report
  • 104 Pages
From
Enbrel Biosimilars Clinical Trial & Opportunity Insight - Product Thumbnail Image

Enbrel Biosimilars Clinical Trial & Opportunity Insight

  • Report
  • 70 Pages
From
Adalimumab Market Analysis: by Applications and Geography - Forecast 2016-2021 - Product Thumbnail Image

Adalimumab Market Analysis: by Applications and Geography - Forecast 2016-2021

  • Report
  • 166 Pages
From
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2018 - Product Thumbnail Image

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2018

  • Report
  • 51 Pages
From
Report package: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-cells - Product Thumbnail Image

Report package: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-cells

  • Report
  • 618 Pages
From
Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets - Product Thumbnail Image

Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets

  • Report
  • 126 Pages
From
Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market - Product Thumbnail Image

Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market

  • Report
  • 125 Pages
From
Global Cancer Monoclonal Antibodies Market - Segmented by Type of Monoclonal Antibody, and Monoclonal Antibody Therapies, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023) - Product Thumbnail Image

Global Cancer Monoclonal Antibodies Market - Segmented by Type of Monoclonal Antibody, and Monoclonal Antibody Therapies, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)

  • Report
  • 110 Pages
From
Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018 - Product Thumbnail Image

Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018

  • Report
  • 344 Pages
From
Global Dermatology Drugs Market to 2023 - Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis - Product Thumbnail Image

Global Dermatology Drugs Market to 2023 - Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis

  • Report
  • 136 Pages
From
Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2012-2018 - Product Thumbnail Image

Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2012-2018

  • Report
  • 2500 Pages
From
The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment - Product Thumbnail Image

The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment

  • Report
  • 320 Pages
From
Psoriasis Treatments 2012-2013 Patent Landscape - Product Thumbnail Image

Psoriasis Treatments 2012-2013 Patent Landscape

  • Report
  • 82 Pages
From
Monoclonal Antibodies - Global Trends in the Competitive, Technological and R&D Landscape - Product Thumbnail Image

Monoclonal Antibodies - Global Trends in the Competitive, Technological and R&D Landscape

  • Report
  • 57 Pages
From
Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth - Product Thumbnail Image

Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth

  • Report
  • 101 Pages
From
Loading Indicator
adroll